Figure 1
From: Genetics of symptom remission in outpatients with COVID-19
Manhattan plots for the GWAS of time to remission of COVID-19 symptoms. (a) Using a Cox proportional hazards regression with 1723 subjects from the colchicine and placebo arms of the COLCORONA study, controlling for study arm, sex, age, and 10 principal components for genetic ancestry, with 6,392,715 genetic variants of minor allele frequency ≥ 5%. (b) Using a Cox proportional hazards regression with 851 subjects from the placebo arm of the COLCORONA study, controlling for sex, age, and 10 principal components for genetic ancestry, with 6,390,776 genetic variants of minor allele frequency ≥ 5%.
